Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase igf1r'

Search results for: 'research area tyrosine kinase igf1r'

Items 31-40 of 45

Page
per page
  1. LY2606368
    B1088 LY2606368
    Target: Chk
    Summary: CHK1 inhibitor
      insoluble in DMSO
  2. Poloxin
    A3732 Poloxin
    Target: PLK
    Summary: PLK1 inhibitor
      insoluble in H2O; ≥14.85 mg/mL
  3. PHA-767491
    A3721 PHA-767491
    Target: Cyclin-Dependent Kinases|MK2|Cdc7
    Summary: Cdc7/cdk9 inhibitor, potent, ATP-competitive
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  4. AZ20
    A3210 AZ20
     1 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥20.65 mg/mL
  5. BI 2536
    A3965 BI 2536
     1 Citation
    Target: PLK|Bromodomain-containing proteins(BRDs)
    Summary: Plk1 inhibitor,potent and ATP-competitive
      insoluble in H2O; ≥13.04 mg/mL
  6. GSK2606414
    A3448 GSK2606414
     4 Citation
    Summary: PERK inhibitor,potent and selective
      ≥22.57 mg/mL
  7. Zoledronic Acid
    A1352 Zoledronic Acid
    Target: Farnesyl Diphosphate Synthases
    Summary: Potent nitrogen-containing bisphosphonates
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  8. PF-477736
    B1437 PF-477736
    Target: Chk
    Summary: Chk1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥5.24 mg/mL
  9. NMS-1286937
    B4094 NMS-1286937
    Target: PLK
    Summary: PLK1 inhibitor, orally bioavailable
      insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
  10. CVT-313
    A3336 CVT-313
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Cdk2 inhibitor
      ≥20 mg/mL

Items 31-40 of 45

Page
per page